Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 7.03B |
| Enterprise Value | 6.74B |
| P/E Ratio | -18.87 |
| PEG Ratio | 1.21 |
| Price/Sales Ratio | 6.91 |
| Price/Book Ratio | 1.82 |
| Enterprise/Revenue | 6.67 |
| Enterprise/EBITDA | -29.63 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.37 |
| Operating Margin | -0.35 |
| Return On Assets | -0.08 |
| Return On Equity | -0.09 |
| Revenue | 1.16B |
| Revenue/Share | 0.51 |
| Gross Profit | 241.76M |
| EBITDA | -176.07M |
| Net Income | -379.82M |
| Diluted EPS | -0.18 |
| Total Cash | 1.07B |
| Total Cash/Share | 0.52 |
| Total Debt | 717.05M |
| Total Debt/Equity | 0.18 |
| Current Ratio | 2.09 |
| Book Value Per Share | 1.92 |
| 52-Week Change | 14.52 |
| 52-Week High | 5.11 |
| 52-Week Low | 3.09 |
| Moving Average 50 Days | 4.02 |
| Moving Average 200 Days | 3.82 |
| Average Volume | 80.57M |
| Shares Outstanding | 2.06B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.02 |
| Last Split Factor | 2:1 |
| Last Split Date | May 10, 2016 |